NABL dignitaries visited the national reference laboratory in Navi Mumbai
 
Thyrocare has become the first national diagnostic chain in India to secure 100 per cent National Accreditation Board for Testing and Calibration Laboratories (NABL) across all its 29 laboratories.

The recognition was celebrated at a special event where NABL dignitaries felicitated Thyrocare’s team. The NABL dignitaries visited the national reference laboratory in Navi Mumbai and appreciated the lab infrastructure, analysers, various types of technologies and diverse test menu.
 
Pankaj Johri, Director, NABL, lauded Thyrocare for this extraordinary accomplishment and congratulated Rahul Guha, MD and CEO, hyrocare) and Dr Preet Kaur, Vice President of Operations and Quality, Thyrocare, and team on this magnificent achievement.
 
“From 2022 to 2024, in around two years, Thyrocare received NABL accreditation for 25 of its labs - making 100 per cent of its 29 labs across India NABL-accredited, which is an incredible feat,” remarked Johri.

He added, “This benchmark was achieved while opting for a more stringent Full NABL accreditation to establish trusted quality standards. This full accreditation is more rigorous to achieve than the entry level NABL certification.”

Among other NABL dignitaries who attended this event were Haribabu A, Deputy Director - NABL, Syed Tahira Rizvi, Assistant Director, NABL and Mr Mandeep Dalal - Executive Officer - NABL. N. Venkateswaran, CEO - NABL, also conveyed his congratulations and expressed confidence in Thyrocare’s quality while expanding its reach across India.
 
Adding to the celebration, Chakravarthy T Kannan, Secretary General, Quality Council of India (QCI) appreciated this milestone of Thyrocare.
 
Guha, MD and CEO, Thyrocare said, “The milestone reflects our mission to provide affordable, high-quality diagnostics nationwide. Becoming the First National Diagnostic Brand with 100 per cent of its labs to be NABL-accredited was a vision set 2 years ago. Over the past two years, we have worked diligently to ensure that all 29 labs of Thyrocare meet the rigorous NABL standards. I appreciate NABL’s guidance and support in this journey.”
 
Dr Kaur, shared, “We have a strong network of 29 labs across India. Labs are strategically positioned to minimise sample travel time, reduce preanalytical delays and ensure faster reporting. We have made a huge investment in revamping the entire analyzer base across all the labs. These highly state-of-the-art analyzers along with advanced third-generation reagents ensure high precision in our reports.”